BLAIR WILLIAM & CO/IL - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 118 filers reported holding ACCELERATE DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 18.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
BLAIR WILLIAM & CO/IL ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q1 2023$32,117
-0.8%
45,8810.0%0.00%
Q4 2022$32,392
-87.4%
45,881
-72.9%
0.00%
-100.0%
Q3 2022$258,000
+369.1%
169,543
+208.6%
0.00%
Q2 2022$55,000
-94.3%
54,943
-91.8%
0.00%
-100.0%
Q1 2022$961,000
-72.7%
667,100
-1.1%
0.00%
-72.7%
Q4 2021$3,520,000
-31.2%
674,300
-23.1%
0.01%
-35.3%
Q3 2021$5,114,000
-25.4%
877,187
+3.1%
0.02%
-29.2%
Q2 2021$6,856,000
-3.5%
850,590
-0.4%
0.02%
-11.1%
Q1 2021$7,107,000
+254.5%
854,231
+223.0%
0.03%
+285.7%
Q4 2020$2,005,000
-63.2%
264,507
-48.3%
0.01%
-69.6%
Q3 2020$5,452,000
-32.4%
511,454
-3.9%
0.02%
-39.5%
Q2 2020$8,070,000
+80.9%
532,299
-0.6%
0.04%
+35.7%
Q1 2020$4,462,000
-51.6%
535,673
-1.8%
0.03%
-40.4%
Q4 2019$9,219,000
-38.3%
545,500
-32.2%
0.05%
-45.3%
Q3 2019$14,938,000
-13.7%
804,416
+6.4%
0.09%
-13.1%
Q2 2019$17,304,000
+18.5%
756,296
+8.9%
0.10%
+11.2%
Q1 2019$14,599,000
+98.5%
694,522
+8.6%
0.09%
+64.8%
Q4 2018$7,356,000
-63.5%
639,665
-27.2%
0.05%
-56.5%
Q3 2018$20,165,000
+40.1%
878,655
+36.2%
0.12%
+26.5%
Q2 2018$14,389,000
-0.2%
645,247
+2.3%
0.10%
-3.9%
Q1 2018$14,417,000
-46.0%
630,944
-38.1%
0.10%
-43.6%
Q4 2017$26,718,000
+25.6%
1,019,763
+7.7%
0.18%
+13.8%
Q3 2017$21,267,000
-1.3%
947,293
+20.3%
0.16%
-1.9%
Q2 2017$21,538,000
+24.5%
787,483
+15.1%
0.16%
+16.5%
Q1 2017$17,293,000
+30.7%
684,207
+7.3%
0.14%
+17.8%
Q4 2016$13,232,000
-8.5%
637,690
+20.2%
0.12%
-7.8%
Q3 2016$14,460,000
+273.9%
530,441
+97.4%
0.13%
+255.6%
Q2 2016$3,867,000
+244.0%
268,704
+243.4%
0.04%
+227.3%
Q1 2016$1,124,000
+62.0%
78,245
+142.0%
0.01%
+57.1%
Q4 2015$694,000
+130.6%
32,335
+73.7%
0.01%
+133.3%
Q3 2015$301,000
-94.4%
18,620
-91.0%
0.00%
-62.5%
Q2 2015$5,336,000
+1944.4%
206,775
+1682.5%
0.01%
Q1 2015$261,000
-28.7%
11,600
-39.3%
0.00%
-100.0%
Q4 2014$366,000
-10.7%
19,1000.0%0.00%0.0%
Q3 2014$410,000
-7.7%
19,100
+11.7%
0.00%0.0%
Q2 2014$444,000
+88.9%
17,100
+58.1%
0.00%
Q1 2014$235,00010,8150.00%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Birchview Capital, LP 4,387,590$46,772,00015.62%
ORACLE INVESTMENT MANAGEMENT INC 4,091,749$43,618,0005.75%
GRIFFIN ASSET MANAGEMENT, INC. 1,439,613$15,346,0002.36%
Selkirk Management LLC 348,805$3,718,0001.18%
Chicago Capital, LLC 1,966,891$20,967,0001.08%
Trellus Management Company, LLC 46,834$499,0000.51%
Cannell & Co. 1,118,439$11,923,0000.44%
OAKTOP CAPITAL MANAGEMENT II, L.P. 155,000$1,652,0000.36%
Belpointe Asset Management LLC 419,406$3,982,0000.27%
TCI Wealth Advisors, Inc. 55,586$593,0000.23%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders